Align Technology (ALGN) Aperçu de l'action
Align Technology, Inc. fournit des gouttières transparentes Invisalign, des appareils de rétention Vivera et des scanners intra-oraux iTero ainsi que des services aux États-Unis, en Suisse et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 1/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
ALGN Community Fair Values
Create NarrativeSee what 59 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
US$154.62
FV
5.4% surévalué décote intrinsèque4.80%
Revenue growth p.a.
201
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Align Technology, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$163.04 |
| Plus haut sur 52 semaines | US$200.44 |
| Plus bas sur 52 semaines | US$122.00 |
| Bêta | 1.65 |
| Variation sur 1 mois | -6.86% |
| Variation sur 3 mois | 0% |
| Variation sur 1 an | 13.55% |
| Variation sur 3 ans | -54.65% |
| Variation sur 5 ans | -77.26% |
| Évolution depuis l'introduction en bourse | 841.75% |
Nouvelles et mises à jour récentes
Seeking Alpha • Aug 07
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking Alpha
Mise à jour du récit • Jul 30
ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution
Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.Recent updates
Seeking Alpha • Aug 07
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking AlphaMise à jour du récit • Jul 30
ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution
Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.
Mise à jour du récit • Jul 01
ALGN: Platform Execution And Limited EU Antitrust Impact Will Drive Repricing
Align Technology's updated analyst price target moves higher to $209.07, with analysts pointing to detailed platform growth levers and limited expected fundamental impact from the EU antitrust case as key supports for the revised fair value and P/E assumptions. Analyst Commentary Analysts covering Align Technology describe a mix of supportive long-term growth drivers and near term headline risks, with recent price targets and commentary reflecting how they weigh platform execution against regulatory uncertainty.
Mise à jour du récit • Jun 17
ALGN: Multi-Year Upside Will Rely On Platform Expansion And Direct Fabrication
Align Technology's latest narrative update keeps the fair value unchanged at $240.00. Analysts point to a slightly lower discount rate, modestly adjusted revenue growth and profit margin assumptions, and Street research highlighting teen conversion, restorative treatment partnerships, software improvements, and direct fabrication scaling as reasons for a higher collective price target outlook.Mise à jour du récit • Jun 02
ALGN: Future Returns Will Rely On Execution And Elliott Engagement
Analysts have nudged their price expectations for Align Technology higher, setting a new target of $175.00. This view is supported by the belief that multiple growth levers across teen conversion, restorative treatments, peer-to-peer expansion, software evolution, and manufacturing scale may not yet be fully reflected in the current stock price.Article d’analyse • May 18
We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...Mise à jour du récit • May 12
ALGN: Higher Future Multiple Will Depend On Execution And Elliott Engagement
Narrative Update on Align Technology The updated analyst price target for Align Technology moves to $175.00 from $152.60, with analysts citing a higher assumed future P/E multiple, along with slightly lower modeled revenue growth and profit margins, as key reasons for the change. Analyst Commentary Recent research on Align Technology reflects a mix of optimism and caution, with several firms adjusting price targets and ratings over the past few months.Mise à jour du récit • Apr 21
ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst
The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.Mise à jour du récit • Apr 07
ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing
The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.Mise à jour du récit • Mar 23
ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward
Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.Mise à jour du récit • Mar 08
ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions
The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.Mise à jour du récit • Feb 22
ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook
Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.Mise à jour du récit • Feb 08
ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story
Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.Mise à jour du récit • Jan 25
ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook
Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.Mise à jour du récit • Jan 10
ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations
Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.Article d’analyse • Jan 04
Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Mise à jour du récit • Dec 21
ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp
Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.Mise à jour du récit • Dec 07
ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp
Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.Mise à jour du récit • Nov 23
ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum
Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.Mise à jour du récit • Nov 08
ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook
Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.Mise à jour du récit • Oct 24
Digital Workflow Improvements And Market Weakness Will Shape The Coming Year
Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.Mise à jour du récit • Oct 10
Emerging Markets And Digital Workflow Will Fuel Future Success
Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.Seeking Alpha • Mar 07
Align Technology: Brace Yourself, This Stock Is Undervalued
Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking AlphaRendement pour les actionnaires
| ALGN | US Medical Equipment | US Marché | |
|---|---|---|---|
| 7D | -6.3% | 0.8% | -0.8% |
| 1Y | 13.6% | -11.1% | 20.5% |
Rendement vs Industrie: ALGN a dépassé le secteur US Medical Equipment qui a rapporté -11.1 % au cours de l'année écoulée.
Rendement vs marché: ALGN a sous-performé le marché US qui a rapporté 20.5 % au cours de l'année écoulée.
Volatilité des prix
| ALGN volatility | |
|---|---|
| ALGN Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Cours de l'action stable: ALGN n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de ALGN ( 6% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1997 | 20,435 | Joe Hogan | www.aligntech.com |
Align Technology, Inc. propose des gouttières transparentes Invisalign, des appareils de rétention Vivera et des scanners intra-oraux iTero, ainsi que des services aux États-Unis, en Suisse et à l'étranger. Le segment des aligneurs transparents de l'entreprise propose l'ensemble complet Invisalign pour traiter les malocclusions et les caractéristiques des adultes et des adolescents, ainsi que les besoins orthodontiques des patients adolescents ou plus jeunes ; et les ensembles Invisalign First Phase I et Invisalign First Comprehensive Phase 2 pour les jeunes patients âgés de six à dix ans avec un mélange de dents primaires/de lait et de dents permanentes. Ce segment propose également Invisalign express, Invisalign lite et Invisalign moderate ; Invisalign Go, Invisalign Go express et Invisalign Go Plus ; des produits de rétention, des formations Invisalign, des outils d'ajustement utilisés par les professionnels dentaires pendant le traitement, des produits accessoires Invisalign et d'autres produits de santé bucco-dentaire ; le système de blanchiment Invisalign Professional ; Invisalign Palatal Expander, un dispositif orthodontique imprimé en 3D ; et des solutions d'impression en 3D.
Align Technology, Inc. Résumé des fondamentaux
| ALGN statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$11.93b |
| Bénéfices(TTM) | US$413.58m |
| Recettes(TTM) | US$4.14b |
28.0x
Ratio P/E2.8x
Ratio P/SLe site ALGN est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| ALGN compte de résultat (TTM) | |
|---|---|
| Recettes | US$4.14b |
| Coût des recettes | US$1.23b |
| Marge brute | US$2.91b |
| Autres dépenses | US$2.50b |
| Les revenus | US$413.58m |
Derniers bénéfices déclarés
Jun 30, 2026
Prochaine date de publication des résultats
Oct 28, 2026
| Résultat par action (EPS) | 5.82 |
| Marge brute | 70.36% |
| Marge bénéficiaire nette | 9.99% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de ALGN?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/08/19 16:43 |
| Cours de l'action en fin de journée | 2026/08/19 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Align Technology, Inc. est couverte par 42 analystes. 16 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Charley Jones | Barrington Research Associates, Inc. |